SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-12-070581
Filing Date
2012-10-23
Accepted
2012-10-23 16:05:46
Documents
17
Period of Report
2012-10-23
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a12-24595_18k.htm 8-K 25894
2 EX-99.1 a12-24595_1ex99d1.htm EX-99.1 23362
3 GRAPHIC g245951moi001.gif GRAPHIC 47933
4 GRAPHIC g245951moi002.gif GRAPHIC 31651
5 GRAPHIC g245951moi003.gif GRAPHIC 44080
6 GRAPHIC g245951moi004.gif GRAPHIC 72104
7 GRAPHIC g245951moi005.gif GRAPHIC 81171
8 GRAPHIC g245951moi006.gif GRAPHIC 73044
9 GRAPHIC g245951moi007.gif GRAPHIC 70815
10 GRAPHIC g245951moi008.gif GRAPHIC 76567
11 GRAPHIC g245951moi009.gif GRAPHIC 67748
12 GRAPHIC g245951moi010.gif GRAPHIC 82291
13 GRAPHIC g245951moi011.gif GRAPHIC 63689
14 GRAPHIC g245951moi012.gif GRAPHIC 91729
15 GRAPHIC g245951moi013.gif GRAPHIC 123454
16 GRAPHIC g245951moi014.gif GRAPHIC 78717
17 GRAPHIC g245951moi015.gif GRAPHIC 58220
  Complete submission text file 0001104659-12-070581.txt   1517550
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 121156633
SIC: 2834 Pharmaceutical Preparations